#GLP1R agonist, #semaglutide #tirzepatide improve eGFR slope compared to placebo and/or Insulin for #DKD. Wonderful analysis by David Cherney and Hiddo Heerspink.#KidneyWk

.Walt Disney World Disney Parks @WDWGuestService Disney Orlando Magic CNN CNN International CNN Breaking News ridiculous service from Disney. Being a Mother of a disable cerebral palsy child and many other disabled people like us were made to suffer through their monorail service and no support for

Evolution of #SBP Rx & prophylaxis in #cirrhosis, less is more 🔑Veterans Affairs⬆️cipro resistance in primary prophylaxis pts 🔑Korea, #responseguidedRx🥇for SBP Rx 🔑UK, inpt antibiotics🚫outcomes Read⤵️ pubmed.ncbi.nlm.nih.gov/36645215/ pubmed.ncbi.nlm.nih.gov/36594820/ pubmed.ncbi.nlm.nih.gov/35970815/

🙏@vcunews for highlighting our prior & ongoing #gutbrainaxis research in #alcohol use disorder! news.vcu.edu/article/2023/0… Enrollment in the #IMPACT trial supported by NIAAA News VCU Health has begun⤵️ clinicaltrials.gov/ct2/show/NCT05…

Apparently our APPs asked #chatgpt to write a poem about the loop of henle

Early #paracentesis is associated w/better prognosis compared to late or no-paracentesis in hospitalized veterans w/#cirrhosis & #ascites by @jasmohanbajaj Nilang Patel, MD, MS, FASN et al journals.lww.com/lt/Abstract/99… @vcuresearch VA Research #livertwitter #MedTwitter

A wonderful discussion today in JC by ⁦Dhiren Kumar⁩ on this article. Many patients developed #ODS despite staying < 8 correction! Osmotic Demyelination Syndrome in Patients Hospitalized with Hyponatremia | NEJM Evidence evidence.nejm.org/doi/full/10.10…

Plasma exchange for acute & acute on chronic liver failure: A systematic review & Meta-Analysis by @kavishpatidar11 et al journals.lww.com/lt/Abstract/99… #livertwitter #ACLF

Are 👄🦷part of the digestive system? ✔️ Do dental access #disparities impact #cirrhosis ? ✔️ How can we fix it? ✅commentary Gastroenterology pubmed.ncbi.nlm.nih.gov/38224859/ ✅🇺🇸🇩🇰 MetteMunkLauridsen American Gastroenterological Association (AGA) Prior 👀pubmed.ncbi.nlm.nih.gov/30118351/ pubmed.ncbi.nlm.nih.gov/36328307/ pubmed.ncbi.nlm.nih.gov/28978799/

1 in 9 (10.7%) US adult age > 65 has dementia. So it's vital to look for reversible causes of #dementia. We recently published that 10% of patients with #dementia, could have potentially reversible underlying cause. @VAresearch, @dementiaOrg, @vcuhealth

Among veterans with a diagnosis of dementia, a high Fibrosis-4 score suggestive of advanced liver fibrosis to cirrhosis was observed in 5-10% of the patients who previously did not have a diagnosis of cirrhosis. ja.ma/49k3x3n @jasmohanbajaj Veterans Health

Our study is mentioned ⁦⁦The New York Times⁩ !!!What to Know About Mild Cognitive Impairment Treatment - The New York Times ⁦JAMA Network Open⁩ jamanetwork.com/journals/jaman…. #cirrhosis #dementia ⁦VA Research⁩ ⁦VCU Research⁩ ⁦Nilang Patel, MD, MS, FASN⁩ nytimes.com/2024/02/06/wel…

Our work is being quoted The New York Times. We showed that 10% patients of #dementia could have reversible cause. #cirrhosis Richmond VAMC VA Research

How often should we give #Oral #Iron supplements to patients with #Irondeficiency #anemia? We studied > 70,000 patients with IDA. ⬆️ Hgb🩸is similar in daily and alternate-day groups but happened at a slower pace ⬇️compared to >= 2 times/day. This difference in dose response is

❓How much Hgb🩸increase would you expect if we give oral Iron tablet daily vs. 2-3 times/day vs. alternate day in #Irondeficiency #Anemia 🔑Hgb🩸⬆️ 1.03 g/dL in daily, ⬆️ 1.38 g/dL in >= 2 times/day and ⬆️ 0.93 g/dL in alternate day group at 90 days in patients normal kidney

🙏 EASLnews for invite to present data on #machinelearning to exclude #SBP in VA Research VCU Research cohorts EASLnews #EASLCongress. Great negative predictive value giving hope to those w limited resources. 🙏 Vincent Di Martino for 📸 Nilang Patel, MD, MS, FASN @VCU_CCTR

🙏 for highlighting our VA Research & @TriNetX study! Nilang Patel, MD, MS, FASN Jacqueline O'Leary @VCU_CCTR MedPage Infectious Disease Healio Gastroenterology Global Antibiotic R&D Partnership (GARDP)

CIPHER is excited to announce our partnership with #OHDSI! A core part of OMOP’s Common Data Model, OHDSI’s standardized vocabularies enable the harmonization of terminologies across clinical domains that allows for collaborative research and large-scale analytics. OHDSI

Combination therapy reduced more proteinuria than either agent alone..